Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. (RLMD) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · RLMD · as of Jun 9, 2026
Activity summary
Buy transactions
17
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Relmada Therapeutics, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
RLMD insider buying and selling by quarter
RLMD insider selling · RLMD insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · RLMD ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
RLMD executive sell shares · RLMD board member insider trading · RLMD insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Dec 15, 2025 | TRAVERSA SERGIO CEO · Director | Purchase | 27,500 | $113K | Form 4 |
| Dec 15, 2025 | Shenouda Maged CFO | Purchase | 11,665 | $48K | Form 4 |
| Nov 5, 2025 | Shenouda Maged CFO | Purchase | 500,000 | $1.10M⚡ | Form 4 |
| Nov 5, 2025 | Ence Chuck CAO and COO | Purchase | 136,000 | $299K | Form 4 |
| Nov 5, 2025 | TRAVERSA SERGIO CEO · Director | Purchase | 272,500 | $600K | Form 4 |
| Nov 5, 2025 | Kelly Paul Edward COO · Director | Purchase | 90,000 | $198K | Form 4 |
| Aug 28, 2025 | TRAVERSA SERGIO CEO · Director | Purchase | 55,976 | $41K | Form 4 |
| Aug 27, 2025 | TRAVERSA SERGIO CEO · Director | Purchase | 129,455 | $87K | Form 4 |
| Aug 26, 2025 | TRAVERSA SERGIO CEO · Director | Purchase | 80,545 | $50K | Form 4 |
| May 16, 2025 | Kelly Paul Edward COO · Director | Purchase | 200,000 | $86K | Form 4 |
| May 20, 2025 | Shenouda Maged CFO | Purchase | 60,000 | $31K | Form 4 |
| May 19, 2025 | Shenouda Maged CFO | Purchase | 90,000 | $44K | Form 4 |
| May 16, 2025 | Shenouda Maged CFO | Purchase | 50,000 | $22K | Form 4 |
| May 16, 2025 | Ence Chuck CA and CO | Purchase | 228,961 | $103K | Form 4 |
| May 20, 2025 | TRAVERSA SERGIO CEO · Director | Purchase | 147,686 | $82K | Form 4 |
| May 19, 2025 | TRAVERSA SERGIO CEO · Director | Purchase | 30,000 | $15K | Form 4 |
| May 16, 2025 | TRAVERSA SERGIO CEO · Director | Purchase | 172,314 | $77K | Form 4 |
| Oct 22, 2024 | CASAMENTO CHARLES J Director | Gift | 13,000 | — | Form 4 |
| Sep 11, 2024 | TRAVERSA SERGIO CEO · Director | Purchase | 51,407 | $154K | Form 4 |
| Sep 10, 2024 | TRAVERSA SERGIO CEO · Director | Purchase | 33,014 | $91K | Form 4 |
| Sep 9, 2024 | TRAVERSA SERGIO CEO · Director | Purchase | 55,579 | $151K | Form 4 |
| Sep 9, 2024 | CASAMENTO CHARLES J Director | Purchase | 13,000 | $33K | Form 4 |
| Sep 11, 2024 | Shenouda Maged CFO | Purchase | 24,120 | $71K | Form 4 |
| Sep 10, 2024 | Shenouda Maged CFO | Purchase | 21,118 | $58K | Form 4 |
| Sep 9, 2024 | Shenouda Maged CFO | Purchase | 8,194 | $21K | Form 4 |
TRAVERSA SERGIO
CEO · Director
Date
Dec 15
Shares
27,500
Price
$4.12
Value
$113K
TRAVERSA SERGIO
CEO · Director
Date
Nov 5
Shares
272,500
Price
$2.20
Value
$600K
Kelly Paul Edward
COO · Director
Date
Nov 5
Shares
90,000
Price
$2.20
Value
$198K
TRAVERSA SERGIO
CEO · Director
Date
Aug 28
Shares
55,976
Price
$0.74
Value
$41K
TRAVERSA SERGIO
CEO · Director
Date
Aug 27
Shares
129,455
Price
$0.67
Value
$87K
TRAVERSA SERGIO
CEO · Director
Date
Aug 26
Shares
80,545
Price
$0.62
Value
$50K
Kelly Paul Edward
COO · Director
Date
May 16
Shares
200,000
Price
$0.43
Value
$86K
TRAVERSA SERGIO
CEO · Director
Date
May 20
Shares
147,686
Price
$0.56
Value
$82K
TRAVERSA SERGIO
CEO · Director
Date
May 19
Shares
30,000
Price
$0.50
Value
$15K
TRAVERSA SERGIO
CEO · Director
Date
May 16
Shares
172,314
Price
$0.45
Value
$77K
TRAVERSA SERGIO
CEO · Director
Date
Sep 11
Shares
51,407
Price
$2.99
Value
$154K
TRAVERSA SERGIO
CEO · Director
Date
Sep 10
Shares
33,014
Price
$2.75
Value
$91K
TRAVERSA SERGIO
CEO · Director
Date
Sep 9
Shares
55,579
Price
$2.71
Value
$151K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About RLMD insider trading
RLMD insider trades
Relmada Therapeutics, Inc. (RLMD) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including TRAVERSA SERGIO (CEO · Director), Shenouda Maged (CFO), Ence Chuck (CAO and COO). Over the past 12 months, 4 insiders have filed transactions with the SEC. RLMD insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Relmada Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
RLMD insider trading · 5 questionsThe insiders of Relmada Therapeutics, Inc. (RLMD) include executives and directors such as TRAVERSA SERGIO (CEO · Director), Shenouda Maged (CFO), Ence Chuck (CAO and COO), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026